{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T19:24:43Z","timestamp":1777836283986,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"China Shanghai Municipal Commission of Health and Family Planning","award":["QKY-2022-12"],"award-info":[{"award-number":["QKY-2022-12"]}]},{"name":"China Shanghai Municipal Commission of Health and Family Planning","award":["w2021-25"],"award-info":[{"award-number":["w2021-25"]}]},{"name":"China Shanghai Municipal Commission of Health and Family Planning","award":["QWJ2022-04"],"award-info":[{"award-number":["QWJ2022-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Although\n                      <jats:italic>schistosomiasis<\/jats:italic>\n                      has been basically eliminated, it has not been completely extinction in China and occasional outbreaks occur in Europe in recent years. The relationship between inflammation caused by\n                      <jats:italic>Schistosoma<\/jats:italic>\n                      japonicum and colorectal cancer (CRC) is still obscure, and the inflammation based prognostic systems of schistosomal colorectal (SCRC) has rarely been reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>\n                      To explore the different roles of tumor infiltrating lymphocytes (TILs) and C-reactive protein (CRP) in SCRC and in Non-schistosomal CRC (NSCRC), providing a possible predictive system to evaluate outcomes and to improve the risk stratification for CRC patients, especially for CRC patients with\n                      <jats:italic>schistosomiasis<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three hundred fifty-one CRC tumors were evaluated for density of CD4\u2009+\u2009, CD8\u2009+\u2009T cells and CRP in intratumoral and stromal compartments by immunohistochemical using tissue microarray.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were no association between TILs and CRP and\n                      <jats:italic>schistosomiasis<\/jats:italic>\n                      . Multivariate analysis identified stromal CD4 (sCD4) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.038), intratumoral CD8 (iCD8) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003),\n                      <jats:italic>schistosomiasis<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.045) as independent prognostic factors for overall survival (OS) in the whole cohort; and sCD4 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006) and iCD8 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.020) were independent prognostic factors for OS in the NSCRC and SCRC set, respectively. Besides, we found that there were no differences of TILs and CRP, which were distributed in different areas of tumor tissue, between CRC patients with and without\n                      <jats:italic>schistosomiasis<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The results remind us that different subtypes of TILs have distinguished biological behavior and prognosis value in the immune microenvironment of NSCRC and SCRC patients. Meanwhile, the findings require us to stratify patients with\n                      <jats:italic>schistosomiasis<\/jats:italic>\n                      and this might facilitate patient counseling and management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-023-02834-z","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T07:02:08Z","timestamp":1685948528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The predictive value of CD4, CD8, and C\u2014reactive protein in the prognosis of schistosomal and non-schistosomal colorectal cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Meihong","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dacheng","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jican","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qilin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"issue":"7","key":"2834_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1471-4922(02)02301-2","volume":"18","author":"NR Bergquist","year":"2002","unstructured":"Bergquist NR. Schistosomiasis: from risk assessment to control. Trends Parasitol. 2002;18(7):309\u201314.","journal-title":"Trends Parasitol"},{"issue":"3","key":"2834_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00281-020-00799-9","volume":"42","author":"DP McManus","year":"2020","unstructured":"McManus DP, et al. Correction to: Schistosomiasis-from immunopathology to vaccines. Semin Immunopathol. 2020;42(3):373\u20134.","journal-title":"Semin Immunopathol"},{"issue":"8","key":"2834_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/pim.12087","volume":"36","author":"DG Colley","year":"2014","unstructured":"Colley DG, Secor WE. Immunology of human schistosomiasis. Parasite Immunol. 2014;36(8):347\u201357.","journal-title":"Parasite Immunol"},{"issue":"1","key":"2834_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/01635589309514266","volume":"20","author":"W Guo","year":"1993","unstructured":"Guo W, et al. Correlations of colon cancer mortality with dietary factors, serum markers, and schistosomiasis in China. Nutr Cancer. 1993;20(1):13\u201320.","journal-title":"Nutr Cancer"},{"issue":"7","key":"2834_CR5","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/1097-0142(19801001)46:7<1661::AID-CNCR2820460728>3.0.CO;2-O","volume":"46","author":"C Ming-Chai","year":"1980","unstructured":"Ming-Chai C, et al. Evolution of colorectal cancer in schistsosomiasis: transitional mucosal changes adjacent to large intestinal carcinoma in colectomy specimens. Cancer. 1980;46(7):1661\u201375.","journal-title":"Cancer"},{"issue":"1","key":"2834_CR6","first-page":"64","volume":"104","author":"XR Yu","year":"1991","unstructured":"Yu XR. Histological classification of schistosomal egg induced polyps of colon and their clinical significance. An analysis of 272 cases. Chin Med J (Engl). 1991;104(1):64\u201370.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"2834_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12957-020-01925-5","volume":"18","author":"W Wang","year":"2020","unstructured":"Wang W, et al. Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer. World J Surg Oncol. 2020;18(1):149.","journal-title":"World J Surg Oncol"},{"issue":"2","key":"2834_CR8","first-page":"64","volume":"13","author":"OS Ojo","year":"1992","unstructured":"Ojo OS, Odesanmi WO, Akinola OO. The surgical pathology of colorectal carcinomas in Nigerians. Trop Gastroenterol. 1992;13(2):64\u20139.","journal-title":"Trop Gastroenterol"},{"issue":"1","key":"2834_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12957-019-1621-9","volume":"17","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, et al. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. World J Surg Oncol. 2019;17(1):85.","journal-title":"World J Surg Oncol"},{"key":"2834_CR10","first-page":"4","volume":"7","author":"H Ohtani","year":"2007","unstructured":"Ohtani H. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun. 2007;7:4.","journal-title":"Cancer Immun"},{"issue":"4","key":"2834_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1189\/jlb.1107773","volume":"84","author":"F Pages","year":"2008","unstructured":"Pages F, Galon J, Fridman WH. The essential role of the in situ immune reaction in human colorectal cancer. J Leukoc Biol. 2008;84(4):981\u20137.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"2834_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.0105-2896.2010.00899.x","volume":"235","author":"R Arens","year":"2010","unstructured":"Arens R, Schoenberger SP. Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev. 2010;235(1):190\u2013205.","journal-title":"Immunol Rev"},{"issue":"6","key":"2834_CR13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/j.1464-410X.2008.07666.x","volume":"102","author":"GW Lamb","year":"2008","unstructured":"Lamb GW, et al. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer. BJU Int. 2008;102(6):756\u201361.","journal-title":"BJU Int"},{"issue":"5","key":"2834_CR14","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1523-1755.2005.00666.x","volume":"68","author":"WJ Jabs","year":"2005","unstructured":"Jabs WJ, et al. Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. Kidney Int. 2005;68(5):2103\u201310.","journal-title":"Kidney Int"},{"issue":"2","key":"2834_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/SLA.0000000000003239","volume":"272","author":"Y Okugawa","year":"2020","unstructured":"Okugawa Y, et al. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer. Ann Surg. 2020;272(2):342\u201351.","journal-title":"Ann Surg"},{"issue":"10","key":"2834_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s10552-014-0445-8","volume":"25","author":"B Zhou","year":"2014","unstructured":"Zhou B, et al. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis. Cancer Causes Control. 2014;25(10):1397\u2013405.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"2834_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/jjco\/hyz210","volume":"50","author":"W Pan","year":"2020","unstructured":"Pan W, et al. The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer. Jpn J Clin Oncol. 2020;50(4):446\u201355.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"2834_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.humpath.2015.08.007","volume":"47","author":"VH Koelzer","year":"2016","unstructured":"Koelzer VH, Zlobec I, Lugli A. Tumor budding in colorectal cancer\u2013ready for diagnostic practice? Hum Pathol. 2016;47(1):4\u201319.","journal-title":"Hum Pathol"},{"issue":"5","key":"2834_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.humpath.2012.07.026","volume":"44","author":"M Horcic","year":"2013","unstructured":"Horcic M, et al. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. Hum Pathol. 2013;44(5):697\u2013705.","journal-title":"Hum Pathol"},{"issue":"4","key":"2834_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, et al. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298\u2013306.","journal-title":"Nat Rev Cancer"},{"issue":"35","key":"2834_CR21","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1200\/JCO.2008.19.6147","volume":"27","author":"F Pages","year":"2009","unstructured":"Pages F, et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol. 2009;27(35):5944\u201351.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2834_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00262-016-1826-5","volume":"65","author":"F Noble","year":"2016","unstructured":"Noble F, et al. Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma. Cancer Immunol Immunother. 2016;65(6):651\u201362.","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"2834_CR23","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1093\/annonc\/mdw319","volume":"27","author":"T Kinoshita","year":"2016","unstructured":"Kinoshita T, et al. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer. Ann Oncol. 2016;27(11):2117\u201323.","journal-title":"Ann Oncol"},{"issue":"3","key":"2834_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.bjc.6601943","volume":"91","author":"PA McArdle","year":"2004","unstructured":"McArdle PA, et al. The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer. Br J Cancer. 2004;91(3):541\u20133.","journal-title":"Br J Cancer"},{"issue":"10","key":"2834_CR25","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/sj.bjc.6601400","volume":"89","author":"EJ Bromwich","year":"2003","unstructured":"Bromwich EJ, et al. The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br J Cancer. 2003;89(10):1906\u20138.","journal-title":"Br J Cancer"},{"key":"2834_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2407-12-134","volume":"12","author":"R Droeser","year":"2012","unstructured":"Droeser R, et al. Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers. BMC Cancer. 2012;12:134.","journal-title":"BMC Cancer"},{"issue":"8","key":"2834_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41416-019-0559-6","volume":"121","author":"T Kuwahara","year":"2019","unstructured":"Kuwahara T, et al. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer. Br J Cancer. 2019;121(8):659\u201365.","journal-title":"Br J Cancer"},{"issue":"4","key":"2834_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/10408363.2011.599831","volume":"48","author":"KH Allin","year":"2011","unstructured":"Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48(4):155\u201370.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"10","key":"2834_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/codi.12700","volume":"16","author":"S Pathak","year":"2014","unstructured":"Pathak S, et al. Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review Colorectal Dis. 2014;16(10):769\u201376.","journal-title":"A systematic review Colorectal Dis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02834-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-023-02834-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02834-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T07:03:08Z","timestamp":1685948588000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-023-02834-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2834"],"URL":"https:\/\/doi.org\/10.1186\/s12876-023-02834-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1958234\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"13 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the medical ethics committee of Fudan University, in accordance with the Helsinki Declaration of 1975. Prior written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}